April 25, 2023 — FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the issuance of its second utility patent by the USPTO.

April 25, 2023 — A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation ablation, according to late breaking science presented at EHRA 2023, the annual congress of the European Heart Rhythm Association (EHRA) – a branch of the European Society of Cardiology (ESC).1 

April 25, 2023 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, announced that the European Patent Office has granted Patent No.


The AiMed Global Summit 2023 will take place June 4-7 at the San Diego Convention Center in San Diego, Calif., with the theme “Changing Healthcare One Connection at a Time.” Throughout the summit, attendees will have the opportunity to network with 1,500 healthcare game-changers and hear from top AI key opinion leaders, gaining expert insights, proven best practices and real-world success stories.


April 24, 2023 — Using powerful sequencing technology, researchers have identified specific biomarker patterns in the blood that are unique to severe COVID-19 infection, as well as others unique to Multisystem Inflammatory Syndrome in Children (

April 24, 2023 — -RapidAI, a global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, announced it has received FDA 510(k) clearance for 


The European interventional cardiology device market is one of the larger markets in the global space. The market is driven by the regions aging population and the health care systems demands for various medical devices. However, like the rest of the globe, Europe is seeing a rapidly aging population who are requiring more cardiac care in addition to a decline in overall cardiovascular health.


April 21, 2023 — A Michigan Medicine study finds that Black and socioeconomically disadvantaged patients with a common vascular disease have more severe symptoms before bypass surgery – and are at greater risk for amputation and other complications after the procedure. 

Subscribe Now